Current advances on RIPK2 and its inhibitors in pathological processes: a comprehensive review
Receptor-Interacting Protein Kinase 2 (RIPK2) is a critical component of the signaling pathways downstream of Nucleotide-binding oligomerization domain-like receptor (NOD-like receptor), playing a vital role in the immune response, particularly in the context of cellular transport, adaptive immunity...
Saved in:
| Main Authors: | Shanshan Shen, Chen Lu, Tao Ling, Yanan Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Molecular Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2025.1492807/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deubiquitination of RIPK3 by OTUB2 potentiates neuronal necroptosis after ischemic stroke
by: Fuqi Mei, et al.
Published: (2025-02-01) -
Serum Level of RIPK1/3 Correlated With the Prognosis in ICU Patients With Acute Ischemic Stroke
by: Jianhong Dong, et al.
Published: (2024-12-01) -
A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injury
by: Liang Ouyang
Published: (2025-07-01) -
Effects of global Ripk2 genetic deficiency in aged mice following experimental ischemic stroke
by: John Aaron Howell, et al.
Published: (2025-01-01) -
Receptor interacting protein kinase 1 activation and triggering mesangial cells necroptosis in MRL/lpr mice model of lupus nephritis
by: Lin Peng, et al.
Published: (2025-12-01)